维普中文期刊产品整合服务
18篇 您的检索式:作者名="RASPAGLIO G"
    题名 作者 年代 出处 被引量
1Antitumour activity of the silybin-phosphatidylcholine complex,IdB 1016,against human ovarian cancer显示文摘Gallo D Giacomelli S Ferlini C Raspaglio G Apollonio P Prislei S Riva A Morazzoni P Bombardelli E Scambia G 0,,:1
2Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance显示文摘Ferlini C Raspaglio G Mozzetti S 2003Mol Pharmacol2003,64,1:1
3Analysis of DNA alkylation damage and repair in mammalian cells by the comet assay显示文摘Fortini P Raspaglio G Falchi M 1996Mutagenesis1996,11,2:1
4hMSH2 and GTBP expression in advanced stage epithelial ovarian cancer 显示文摘Ercoli A Ferrandina G Raspaglio G 1999Br J Cancer1999,,:1
5Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melano- ma 显示文摘DE STEFANO I RASPAGLIO G ZANNONI G F 2009Biochemical Pharmacology2009,78,11:1
6Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance 显示文摘Ferlini C Raspaglio G Mozzetti S 2003Mol Pharmacol2003,64,1:1
7The seco-taxane IDN5390 is able to target class III beta-tubulin and to overcome paclitaxel resistance显示文摘Ferlini C Raspaglio G Mozzetti S 0,,06:1
8Bcl-2 down-regulation is a novel mechanismof paclitaxel resistance 显示文摘Ferlini C Raspaglio G Mozzetti S 2003Mol Pharmacol2003,64,1:1
9HuR regu- lates beta- tubuhn isotype expression in ovarian cancer显示文摘RASPAGLIO G DE MARIA I FILIPPETTI F 2010Cancer Res2010,70,14:1
10HuR regulates beta- tubulin isotype expression in ovarian cancer 显示文摘Raspaglio G De Maria I Filippetti F 2010Cancer Res2010,70,14:1
11bcl-2 down-regulation is a novel mechanism of paelitaxel resistance显示文摘Ferlini C Raspaglio G Mozzetti S 2003Mol-Pharmacol2003,64,1:1
12Antitumour activity of the silybin-phosphatidylcholine complex,IdB 1016,against human ovarian cancer显示文摘Gallo D Giacomelli S Ferlini C Raspaglio G Apollonio P Prislei S 2003Eur J Cancer2003,39,16:1
13Bcl-2 down regulation is a novel mechanism of paclitaxel resistance 显示文摘Ferlini C Raspaglio G Mozzetti S 2003Mol Pharmacol2003,24,1:1
14The seco-taxane IDN5390 is able to target class III beta-tubulin and to overcome paelitaxel resistance 显示文摘Ferlini C Raspaglio G Mozzetti S 2005Cancer Res2005,65,6:1
15RON and cisplatin resistance in ovarian cancer cell lines显示文摘Prislei S Mariani M Raspaglio G 2010Oncol Res2010,19,1:1
16HuR regulates beta- tubulin isotype expression in ovarian cancer 显示文摘Raspaglio G De Maria I Filippetti F 2010Cancer Res2010,70,14:1
17Epidermal growth factor-responsive laryngeal squamous cancer cell line Hep2 is more sensitive than unresponsive CO-K3 one to quercetin and tamoxifen apoptotic effects显示文摘Raspaglio G Ferrandina G Ferlini C 2003Oncol Res2003,14,2:1
18Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance显示文摘Ferlini C Raspaglio G Mozzetti S 2003Mol2Pharmacol2003,64,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费